Delivery Order SPE2DB22D2206-SPE2DB23FDZ92
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $44,517.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML SYRINGEML pharmaceutical products. The delivery order was issued under an existing contract with the agency to provide pharmaceuticals, medical supplies, and distribution services to support military treatment programs and facilities. Amerisourcebergen Drug Corp has extensive experience as a prime...
- The Defense Logistics Agency (DLA) awarded a $11,050.35 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML SYRINGEML pharmaceuticals. The award, which has a completion date of January 17, 2024, will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML for $131,662.24. The order was placed on November 23, 2021 and is scheduled to be completed by November 24, 2021. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has a history of supplying pharmaceuticals and medical supplies to DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of STELARA 90 MG/ML SYRINGES. The $7,504.40 contract has a completion date of February 27, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and is the sole recipient of this order, which is not associated with any set-aside designations. In addition to...
- The Defense Logistics Agency (DLA) awarded a $111,675.29 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. The contract did not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGEML. The $31,425.34 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to provide pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML pharmaceutical products. The $127,078.92 award was made on January 11, 2022, with a completion date of January 12, 2022. The order supports DLA's provision of pharmaceuticals and critical care supplies to military treatment programs and facilities. Amerisourcebergen Drug Corp is...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 mg/mL syringes. The $14,035.78 contract has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML pharmaceuticals. The $109,586.50 contract has an October 14, 2021 completion date and was awarded on October 13, 2021. Amerisourcebergen Drug Corp has a long history of providing pharmaceutical and medical supply products and distribution services to support DLA's programs, including...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply STELARA 90 MG/ML syringes. The $48,350.93 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned. This delivery order is likely part of a larger indefinite delivery contract (IDC) Amerisourcebergen holds with...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FDZ92Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $104,498.72 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML pharmaceuticals. This order was placed against an existing indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen Drug Corp, a for-profit organization, has a history of federal contract awards to provide a range of pharmaceutical products and distribution services to U.S. government agencies, primarily the Department of Defense. The contract does not have a set-aside designation and performance will occur at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The delivery order is scheduled for completion on November 8, 2022.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $104.5k | 11/7/22 |